Doberon Tablet 250 Milligrams (Dobesilic Acid Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular lesions and retinopathy: 500~1000mg daily 2. Venous disease: Administer 750mg daily for 1~3 weeks, then 500mg daily. Take after meals with plenty of fluids. The dose may be adjusted according to age and symptoms.

This medication should not be used in patients with allergic reactions to this medication or its components. Additionally, this medication contains lactose, so it should not be administered to patients with genetic disorders that affect lactose digestion. For patients with poor kidney function, the safety and efficacy of this medication have not been adequately studied, so caution should be used, and the dosage may need to be reduced, especially for patients with severe kidney disease requiring dialysis. For patients with impaired liver function, caution is also advised due to a lack of research on the safety of this medication, and treatment should be re-evaluated if liver enzyme levels rise significantly. This medication contains sodium metabisulfite, which may cause allergic reactions or asthma attacks in some individuals, so asthmatics should be especially cautious. While taking this medication, symptoms such as headache, abdominal pain, nausea, diarrhea, vomiting, arthralgia, and myalgia may occur, and if these symptoms are severe, advice from a physician should be sought. Rarely, serious side effects such as a decrease in blood cell count may occur; therefore, if high fever or signs of infection develop, prompt medical attention is necessary. If hypersensitivity reactions occur, the medication should be discontinued immediately and healthcare personnel notified. The effects on driving or operating machinery are unknown, so caution is advised. It is recommended to avoid using this medication during pregnancy, and breastfeeding should also be refrained from; if necessary, treatment or breastfeeding should be discontinued. The safety and efficacy of this medication have not been sufficiently established for children. No special precautions have been reported for elderly patients over 65 years of age. This medication may affect some blood test results, so testing is advised before taking this medication. No specific symptoms have been reported for overdose, but general emergency treatment should be sought.

• Agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• itching
• urticaria
• facial swelling
• anaphylactic reaction
• headache

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance

White oval tablet

Package unit

30 tablets/bottle, 90 tablets/bottle